Utilizing the Fagan plot, the likelihood of HCC diagnosis increased to 84% in patients with elevated AFP levels, while decreasing to 24% in those without elevated AFP levels, based on 50% of patients being diagnosed with HCC (Fig. 3B). This evidence concerns the gene AFP and hepatocellular carcinoma.